AVLN · Avalyn Pharma Inc. · Executive Compensation
$28.22
-0.48 (-1.67%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$1.28B
Shares
44.52M
Volume · Nov 20
42.1K
Avg daily vol (3M)
349.44K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert Meyer, M.D. | Class II director | Appointed | 2026-09-16 |
Leadership
- Robert Meyer, M.D. Board Member
Key facts
CIK
1540171
CUSIP
05348Y105
13F (30d)
112 filings
110 filers
Visit website
Investor relations